Download PDF
Ernährung & Medizin
DOI: 10.1055/a-2439-5831
Wissen

Leaky Gut – ernährungsassoziierte Störung der intestinalen Barriere

Ronny Heldt-Döpel
,
Lisa Schütz
,
Nadine Berling
› Further Information
Also available at
    Permissions and Reprints

Leaky Gut (LG) ist eine Bezeichnung für Beeinträchtigungen der intestinalen Barriere. Diagnostische Ansätze sind bisher kaum evaluiert. Unklar ist auch, ob Barrierestörungen Ursache oder Begleiterscheinung von Erkrankungen sind. Evidenzbasierte Empfehlungen zu Prävention oder Therapie ableiten zu können, ist derzeit nicht möglich und erfordert eine stärkere Forschung zur Ätiologie und gesundheitlichen Bedeutung des LG.



Publication History

Article published online:
07 April 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Camilleri M. What is the leaky gut? Clinical considerations in humans. Curr Opin Clin Nutr Metab Care 2021; 24: 473-482
    PubMedSearch in Google Scholar
  • 2 Aleman RS, Moncada M, Aryana KJ. Leaky gut and the ingredients that help treat it: A review. Molecules 2023; 28: 619
    PubMedSearch in Google Scholar
  • 3 Camilleri M. Leaky gut: mechanisms, measurement and clinical implications in humans. Gut 2019; 68: 1516-1526
    CrossrefPubMedSearch in Google Scholar
  • 4 Kobayashi N, Takahashi D, Takano S. et al. The roles of Peyer’s patches and microfold cells in the gut immune system: Relevance to Autoimmune Diseases. Front Immunol 2019; 10: 2345
    PubMedSearch in Google Scholar
  • 5 Heinemann U, Schuetz A. Structural features of tight-junction proteins. Int J Mol Sci 2019; 20: 6020
    PubMedSearch in Google Scholar
  • 6 Bauer H, Zweimueller-Mayer J, Steinbacher P. et al. The dual role of zonula occludens (ZO) proteins. J Biomed Biotechnol 2010; 2010: 402593
    PubMedSearch in Google Scholar
  • 7 Findley MK, Koval M. Regulation and roles for claudin-family tight junction proteins. IUBMB Life 2009; 61: 431-437
    PubMedSearch in Google Scholar
  • 8 Pelaseyed T, Bergström JH, Gustafsson JK. et al. The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system. Immunol Rev 2014; 260: 8-20
    CrossrefPubMedSearch in Google Scholar
  • 9 Hansson GC. Mucins and the microbiome. Annu Rev Biochem 2020; 89: 769-793
    PubMedSearch in Google Scholar
  • 10 Luis AS, Hansson GC. Intestinal mucus and their glycans: A habitat for thriving microbiota. Cell Host Microbe 2023; 31: 1087-1100
    PubMedSearch in Google Scholar
  • 11 Song C, Chai Z, Chen S. et al. Intestinal mucus components and secretion mechanisms: What we do and do not know. Exp Mol Med 2023; 55: 681-691
    PubMedSearch in Google Scholar
  • 12 Tropini C, Earle KA, Huang KC, Sonnenburg JL. The gut microbiome: Connecting spatial organization to function. Cell Host Microbe 2017; 21: 433-442
    CrossrefPubMedSearch in Google Scholar
  • 13 Ghosh S, Whitley CS, Haribabu B, Jala VR. Regulation of intestinal barrier function by microbial metabolites. Cell Mol Gastroenterol Hepatol 2021; 11: 1463-1482
    CrossrefPubMedSearch in Google Scholar
  • 14 Mörbe UM, Jørgensen PB, Fenton TM. et al. Human gut-associated lymphoid tissues (GALT); diversity, structure, and function. Mucosal Immunol 2021; 14: 793-802
    PubMedSearch in Google Scholar
  • 15 Mowat AM, Agace WW. Regional specialization within the intestinal immune system. Nat Rev Immunol 2014; 14: 667-685
    CrossrefPubMedSearch in Google Scholar
  • 16 Bamias G, Kitsou K, Rivera-Nieves J. The underappreciated role of secretory IgA in IBD. Inflamm Bowel Dis 2023; 29: 1327-1341
    PubMedSearch in Google Scholar
  • 17 Padoan A, Musso G, Contran N, Basso D. Inflammation, autoinflammation and autoimmunityin inflammatory bowel diseases. Curr Issues Mol Biol 2023; 45: 5534-5557
    PubMedSearch in Google Scholar
  • 18 Mu Q, Kirby J, Reilly CM, Luo XM. Leaky gut as a danger signal for autoimmune diseases. Front Immunol 2017; 8: 598
    PubMedSearch in Google Scholar
  • 19 Vanuytsel T, Tack J, Farre R. The role of intestinal permeability in gastrointestinal disorders and current methods of evaluation. Front Nutr 2021; 8: 717925
    PubMedSearch in Google Scholar
  • 20 Khoshbin K, Camilleri M. Effects of dietary components on intestinal permeability in health and disease. Am J Physiol-Gastrointest Liver Physiol 2020; 319: G589-G608
    PubMedSearch in Google Scholar
  • 21 Binienda A, Twardowska A, Makaro A, Salaga M. Dietary carbohydrates and lipids in the pathogenesis of leaky gut syndrome: An overview. Int J Mol Sci 2020; 21: 8368
    CrossrefPubMedSearch in Google Scholar
  • 22 Lerner A, Matthias T. Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease. Autoimmun Rev 2015; 14: 479-489
    PubMedSearch in Google Scholar
  • 23 Camilleri M. Human intestinal barrier: Effects of stressors, diet, prebiotics, and probiotics. Clin Transl Gastroenterol 2021; 12: e00308
    PubMedSearch in Google Scholar
  • 24 Summa KC, Voigt RM, Forsyth CB. et al. Disruption of the circadian clock in mice increases intestinal permeability and promotes alcohol-induced hepatic pathology and inflammation. PLoS One 2013; 8: e67102
    CrossrefPubMedSearch in Google Scholar
  • 25 Moonwiriyakit A, Pathomthongtaweechai N, Steinhagen PR. et al. Tight junctions: From molecules to gastrointestinal diseases. Tissue Barriers 2023; 11: 2077620
    PubMedSearch in Google Scholar
  • 26 Di Tommaso N, Gasbarrini A, Ponziani FR. Intestinal barrier in human health and disease. Int J Environ Res Public Health 2021; 18: 12836
    PubMedSearch in Google Scholar
  • 27 Paone P, Cani PD. Mucus barrier, mucins and gut microbiota: The expected slimy partners?. Gut 2020; 69: 2232-2243
    CrossrefPubMedSearch in Google Scholar
  • 28 Etienne-Mesmin L, Chassaing B, Desvaux M. et al. Experimental models to study intestinal microbes-mucus interactions in health and disease. FEMS Microbiol Rev 2019; 43: 457-489
    PubMedSearch in Google Scholar
  • 29 Christovich A, Luo XM. Gut microbiota, leaky gut, and autoimmune diseases. Front Immunol 2022; 13: 946248
    PubMedSearch in Google Scholar
  • 30 Zegarra-Ruiz DF, El Beidaq A, Iñiguez AJ. et al. A diet-sensitive commensal Lactobacillus strain mediates TLR7-dependent systemic autoimmunity. Cell Host Microbe 2019; 25: 113-127.e6
    PubMedSearch in Google Scholar
  • 31 Smith PM, Howitt MR, Panikov N. et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013; 341: 569-573
    CrossrefPubMedSearch in Google Scholar
  • 32 Malesza IJ, Malesza M, Walkowiak J. et al. High-fat, Western-style diet, systemic inflammation, and gut microbiota: A narrative review. Cells 2021; 10: 3164
    CrossrefPubMedSearch in Google Scholar
  • 33 Amoroso C, Perillo F, Strati F. et al. The role of gut microbiota biomodulators on mucosal immunity and intestinal inflammation. Cells 2020; 9: 1234
    PubMedSearch in Google Scholar
  • 34 Camilleri M, Vella A. What to do about the leaky gut. Gut 2022; 71: 424-435
    PubMedSearch in Google Scholar
  • 35 Biskou O, Jauregi-Miguel A. Measuring intestinal permeability in celiac disease ex vivo, using Ussing chambers. Methods Cell Biol 2023; 179: 21-38
    PubMedSearch in Google Scholar
  • 36 Fritscher-Ravens A, Schuppan D, Ellrichmann M. et al. Confocal endomicroscopy shows food-associated changes in the intestinal mucosa of patients with irritable bowel syndrome. Gastroenterology 2014; 147: 1012-1020.e4
    CrossrefPubMedSearch in Google Scholar
  • 37 Kiesslich R, Duckworth CA, Moussata D. et al. Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease. Gut 2012; 61: 1146-1153
    CrossrefPubMedSearch in Google Scholar
  • 38 Barrett C, Choksi Y, Vaezi MF. Mucosal impedance: A new approach to diagnosing gastroesophageal reflux disease and eosinophilic esophagitis. Curr Gastroenterol Rep 2018; 20: 33
    PubMedSearch in Google Scholar
  • 39 Rao AS, Camilleri M, Eckert DJ. et al. Urine sugars for in vivo gut permeability: Validation and comparisons in irritable bowel syndrome-diarrhea and controls. Am J Physiol-Gastrointest Liver Physiol 2011; 301: G919-G928
    PubMedSearch in Google Scholar
  • 40 Schoultz I, Keita ÅV. The intestinal barrier and current techniques for the assessment of gut permeability. Cells 2020; 9: 1909
    PubMedSearch in Google Scholar
  • 41 Horowitz A, Chanez-Paredes SD, Haest X, Turner JR. Paracellular permeability and tight junction regulation in gut health and disease. Nat Rev Gastroenterol Hepatol 2023; 20: 417-432
    PubMedSearch in Google Scholar
  • 42 Shen L. Tight junctions on the move: Molecular mechanisms for epithelial barrier regulation. Ann N Y Acad Sci 2012; 1258: 9-18
    PubMedSearch in Google Scholar
  • 43 Raftery T, Martineau AR, Greiller CL. et al. Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn’s disease: Results from a randomised double-blind placebo-controlled study. United Eur Gastroenterol J 2015; 3: 294-302
    PubMedSearch in Google Scholar
  • 44 Trompette A, Gollwitzer ES, Yadava K. et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 2014; 20: 159-166
    CrossrefPubMedSearch in Google Scholar
  • 45 Seguella L, Pesce M, Capuano R. et al. High-fat diet impairs duodenal barrier function and elicits glia-dependent changes along the gut-brain axis that are required for anxiogenic and depressive-like behaviors. J Neuroinflamm 2021; 18: 115
    PubMedSearch in Google Scholar
  • 46 Mou Y, Du Y, Zhou L. et al. Gut microbiota interact with the brain through systemic chronic inflammation: Implications on neuroinflammation, neurodegeneration, and aging. Front Immunol 2022; 13: 796288
    PubMedSearch in Google Scholar
  • 47 Ajamian M, Steer D, Rosella G, Gibson PR. Serum zonulin as a marker of intestinal mucosal barrier function: May not be what it seems. PLoS One 2019; 14: e0210728
    PubMedSearch in Google Scholar
  • 48 Chiriac S, Sfarti CV, Minea H. et al. Impaired intestinal permeability assessed by confocal laser endomicroscopy—a new potential therapeutic target in inflammatory bowel disease. Diagnostics 2023; 13: 1230
    PubMedSearch in Google Scholar
  • 49 Martel J, Chang S-H, Ko Y-F. et al. Gut barrier disruption and chronic disease. Trends Endocrinol Metab 2022; 33: 247-265
    PubMedSearch in Google Scholar
  • 50 Martino JV, Van Limbergen J, Cahill LE. The role of carrageenan and carboxymethylcellulose in the development of intestinal inflammation. Front Pediatr 2017; 5: 96
    PubMedSearch in Google Scholar
  • 51 Yazici D, Ogulur I, Pat Y. et al. The epithelial barrier: The gateway to allergic, autoimmune, and metabolic diseases and chronic neuropsychiatric conditions. Semin Immunol 2023; 70: 101846
    PubMedSearch in Google Scholar
  • 52 Roberts CL, Rushworth SL, Richman E, Rhodes JM. Hypothesis: Increased consumption of emulsifiers as an explanation for the rising incidence of Crohn’s disease. J Crohns Colitis 2013; 7: 338-341
    PubMedSearch in Google Scholar
  • 53 Mani V, Hollis JH, Gabler NK. Dietary oil composition differentially modulates intestinal endotoxin transport and postprandial endotoxemia. Nutr Metab 2013; 10: 6
    PubMedSearch in Google Scholar